echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > Studies have found that some antihypertensive drugs can reduce memory decline in the elderly

    Studies have found that some antihypertensive drugs can reduce memory decline in the elderly

    • Last Update: 2021-08-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hypertension is a risk factor leading to cognitive decline and dementia in the elderly


    ACE inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers and diuretics are different classes of antihypertensive drugs


    "Research on which drugs are best for cognition has been mixed," said study author Daniel A.


    This is the first meta-analysis that compares the potential effects of antihypertensive drugs with those that do not cross the blood-brain barrier over time


    "High blood pressure occurs decades before the onset of dementia symptoms and affects not only the blood flow in the body, but also the blood flow in the brain," Nation said


    The researchers collected information on nearly 12,900 adults over 50 years of age from 14 studies


    • During the 3-year follow-up, the elderly who took blood-brain barrier antihypertensive drugs had better memories than those who took drugs that did not cross the blood-brain barrier, even though they had a higher vascular risk


    • During the 3-year follow-up, adults who took hypertensive drugs that did not cross the blood-brain barrier had better attention


    "These findings represent the strongest evidence to date, showing that brain penetration angiotensin receptor inhibitors and angiotensin receptor blockers are associated with better memory


    Blood pressure is considered to be 120/80 mmHg or higher


    The limitation of this analysis is that, according to the existing research, the authors cannot explain the difference in race/ethnic background, and the proportion of men who have taken blood-brain barrier drugs is higher than that of women


    The National Institutes of Health and the Alzheimer's Association funded the research


    Journal Reference :

    1. Jean K.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.